4 | SEC Filings Hub

Filing metadata

Accession number: 0001193125-26-414135
Form type: Form 4
Filer: BridgeBio Oncology Therapeutics, Inc.
CIK: CIK 1869105
Filed: Oct 05, 2026
Reporting period: Oct 01, 2026
Description: Insider transaction

Documents

0001193125-26-414135-index.htm

Complete submission

0001193125-26-414135.txt

directory listing

Filed by

BridgeBio Oncology Therapeutics, Inc.